Financial Performance - The company's operating revenue for Q1 2023 was ¥150,688,090.02, representing a year-on-year increase of 13.62%[5] - The net profit attributable to shareholders decreased by 36.44% to ¥9,424,978.13 compared to the same period last year[5] - Basic and diluted earnings per share were both ¥0.17, down 37.04% from the previous year[6] - Net profit for Q1 2023 was ¥8,840,086.15, a decrease of 39.0% from ¥14,691,594.17 in Q1 2022[20] - The company reported a total comprehensive income of ¥8,840,086.15 for Q1 2023, down from ¥14,691,594.17 in Q1 2022[21] - The net profit for Q1 2023 was ¥7,971,320.63, a decrease of 51.5% from ¥16,441,650.53 in Q1 2022[32] - The total comprehensive income for Q1 2023 was ¥7,971,320.63, compared to ¥16,441,650.53 in Q1 2022, indicating a significant decline[33] Cash Flow and Liquidity - The net cash flow from operating activities was negative at -¥11,598,921.63, a decline of 65.13% year-on-year[5] - Cash received from sales of goods and services in Q1 2023 was ¥87,440,531.29, an increase of 34.5% from ¥65,047,004.12 in Q1 2022[23] - The company's cash and cash equivalents decreased to CNY 66,937,059.60 from CNY 92,594,927.30, representing a decline of approximately 27.8%[15] - Cash and cash equivalents at the end of the period decreased to 67,637,826.91 CNY from 107,519,252.59 CNY year-over-year[25] - The net cash flow from operating activities was -¥11,853,830.89 in Q1 2023, an improvement from -¥34,833,085.53 in Q1 2022[34] Research and Development - Research and development expenses totaled ¥11,143,060.17, accounting for 7.39% of operating revenue, an increase of 0.22 percentage points[6] - The company plans to continue increasing its R&D investment to enhance product development and market competitiveness[9] - Research and development expenses for Q1 2023 were ¥11,143,060.17, an increase of 17.2% compared to ¥9,506,811.68 in Q1 2022[19] - Research and development expenses increased to ¥9,639,594.89 in Q1 2023, up 36.4% from ¥7,062,733.77 in Q1 2022[31] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,377,562,924.69, a slight decrease of 0.10% from the end of the previous year[6] - The company's total assets amounted to CNY 1,377,562,924.69, a slight decrease from CNY 1,378,876,529.32 at the end of 2022[15] - Total liabilities as of Q1 2023 were ¥503,540,648.05, a slight decrease from ¥514,290,121.85 in the previous period[18] - The total current liabilities increased, with accounts payable rising to CNY 225,099,537.39 from CNY 207,115,588.50, an increase of approximately 8.7%[16] - The company's non-current assets totaled CNY 643,270,578.98, up from CNY 613,260,827.70, reflecting an increase of about 4.9%[16] - Total liabilities decreased to 415,389,868.17 CNY from 470,534,422.26 CNY year-over-year[30] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 3,685[11] - The company has a significant shareholder structure, with Gao Changquan holding 35.03% of Yuhuan Huben Investment Partnership, indicating strong family ties in ownership[13] Operating Costs - Total operating costs for Q1 2023 were ¥146,962,316.41, up 24.0% from ¥118,506,937.27 in Q1 2022[19] - The gross profit margin for Q1 2023 was approximately 24.8%, down from 32.5% in Q1 2022[31]
浙海德曼(688577) - 2023 Q1 - 季度财报